Empower Clinical Development by Harnessing Data from Diverse Sources
Please join us next year for DISS 2024!
The Duke-Industry Statistics Symposium (DISS) is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine and several industry and non-profit partners. The symposium was established ten years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.
The symposium (DISS2023) will be held virtually on March 29-31, 2023 with the theme “Empower Clinical Development by Harnessing Data from Diverse Sources”. Clinical development commonly incorporates qualitative information outside of clinical trial settings in treatment evaluations and clinical assessments. Such qualitative information includes prior clinical experience and expert opinions. More recently, new study designs and methods that allow systematically harnessing information from diverse sources of external data, have been proposed. Leveraging external data sources, from historical trials in similar patient populations or with same class treatments to real-world data and real-world evidence, is expected to drastically improve the efficiency of clinical developments.
The first day of the virtual symposium will be devoted to short courses. The following day and a half will consist of keynote speeches, parallel sessions, and poster lightning talk sessions. The Organizing Committee is actively working to finalize the schedule, the topics of various sessions, and invited speakers.
All courses and times for the symposium are in US Eastern Daylight Time (GMT-4).
Please visit this website for ongoing updates about various events.
|Parexel||UCB||ViiV||ASA NC Chapter|
|BeiGene||Journal of Biopharmaceutical Statistics||Intnat'l Chinese Statistical Association||Merck & Co., Inc.|